U.S. Tech Hardware Stock News

If you are wondering whether Visteon shares offer fair value right now, this article walks through what the current price might be implying about the business. The stock last closed at US$98.22, with a 16.2% return over the past year but declines of 3.1% over 7 days, 4.3% over 30 days and 30.6% over both 3 and 5 years, which can change how investors think about its risk and return profile. Recent coverage has focused on how Visteon fits into the broader shift toward more electronics heavy...

Diamondback Energy (FANG) recently filed an 8-K outlining fourth quarter pricing, with average realized oil prices at US$58.00 per barrel, a 9.8% decline from Q3, and weaker natural gas pricing as well. See our latest analysis for Diamondback Energy. That weaker Q4 pricing backdrop comes after a mixed stretch for investors, with a 9.5% 7 day share price return and a 10.3% 90 day share price return contrasting with a 12.0% 1 year total shareholder return decline, while the 5 year total...

If you are wondering whether Old National Bancorp at around US$22.85 is offering fair value or a potential opportunity, it helps to step back and look at what the recent share performance is really telling you. The stock price return data is mixed, with a 0.8% decline over the past 7 days and a 0.6% decline over 30 days, set against gains of 1.3% year to date, 3.0% over 1 year, 41.0% over 3 years, and 48.2% over 5 years. These moves sit against a backdrop where investors are continuously...

Air Products and Chemicals (APD) heads into its upcoming fiscal Q1 2026 earnings with investor attention centered on expected profit growth, improved cost controls last quarter, and a moderately optimistic Wall Street consensus. See our latest analysis for Air Products and Chemicals. The recent focus on upcoming earnings and prior cost discipline sits against a backdrop where the latest share price of $267.25 follows a 9.08% 1 month share price return. However, the 1 year total shareholder...

Helmerich & Payne, Inc. recently announced it will host a conference call on February 5, 2026, to discuss its fiscal first quarter 2026 results, while also attracting fresh attention for long-unresolved invoices and rigs seized in Venezuela. The renewed focus on recovering US$90,000,000 of unpaid invoices and 11 seized rigs in Venezuela adds an additional layer to how investors may think about Helmerich & Payne’s balance sheet strength and international exposure. Next, we’ll examine how the...

USA Rare Earth recently advanced its mining start date at its rare-earth deposit to 2028 and plans to commission its Stillwater, Oklahoma, rare-earth magnet manufacturing facility in early 2026, completing more of the value chain within the U.S. By pairing earlier mining with domestic magnet production and alternative supply from the U.K., the company aims to lessen reliance on Chinese rare-earth exports amid evolving geopolitical and trade conditions. We’ll now examine how USA Rare Earth’s...

Western Union (WU) is back on investor radars after beating EPS estimates, raising full year guidance above peers, and pairing that financial update with a push into digital payments and a planned US Dollar Payment Token on Solana. See our latest analysis for Western Union. The recent earnings beat, higher full year guidance and push into digital products tie in with a 16.3% 90 day share price return. At the same time, the 1 year total shareholder return of a 0.9% decline and 5 year total...

Pagaya Technologies recently highlighted its AI-driven financial services platform at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, part of a broader schedule of investor events featuring its management team. Alongside this expanded investor outreach, the chief development officer executed a pre-planned Rule 10b5-1 share sale in December while retaining a substantial holding following the company’s raised full-year guidance. Next, we’ll examine how...

In early January 2026, Zai Lab reported that China’s NMPA approved a supplemental New Drug Application for AUGTYRO (repotrectinib) to treat adult patients with locally advanced or metastatic solid tumors harboring NTRK gene fusions who have progressed on prior therapies or lack satisfactory alternatives. This marks China’s first approval of a treatment spanning both TRK TKI‑naive and TRK TKI‑pretreated solid tumor patients, reinforcing AUGTYRO’s role in addressing resistance to earlier...

Advance Auto Parts recently appointed Richard “Dick” A. Johnson, former CEO, President and Chairman of Foot Locker, as an independent director to its Board, adding decades of retail leadership and governance experience. Johnson’s current role as Chairman of H & R Block and board positions at several consumer-facing companies may give Advance Auto Parts access to broader retail insights and operational discipline as it executes its ongoing transformation. Now we’ll examine how adding...

Akamai Technologies (AKAM) has attracted fresh attention after recent share price moves, with the stock showing different return profiles over the past week, month, and past 3 months compared with its 1 year performance. See our latest analysis for Akamai Technologies. At a latest share price of US$90.65, Akamai Technologies has seen short term momentum build, with a 90 day share price return of 24.25%, while its 1 year total shareholder return of 0.14% points to a much flatter longer term...

If you are wondering whether Hecla Mining's share price still offers value after a strong run, this article will walk through what the current market price may be implying. The stock recently closed at US$23.80, with returns of 11.4% over 7 days, 26.3% over 30 days, 26.1% year to date, 340.9% over 1 year, 305.3% over 3 years and 336.5% over 5 years, which has sharpened the focus on what is already priced in. Recent coverage has highlighted Hecla Mining's position in precious metals and...

Leadership transitions at Hormel and why they matter for HRL stock Hormel Foods (HRL) has announced the upcoming retirements of Mark Morey, vice president of operations for fresh pork, and Paul Peil, vice president of marketing for fresh and ready meats, drawing attention to succession plans and business continuity. Both executives are credited with shaping growth and transformation across key protein and prepared foods categories. Investors may watch closely to see how Hormel allocates...

If you are wondering whether FTI Consulting at around US$175 per share is offering fair value or a potential mispricing, you are not alone. The stock has been relatively steady in the short term, with a 0.4% decline over the last 7 days, a 2.8% return over the last month, and a 2.9% return year to date. This sits alongside a 9.2% decline over the last year, but gains of 13.0% over 3 years and 50.2% over 5 years. Recent attention on FTI Consulting has reflected how the market is reassessing...

A sharp rise in call option trading on POET Technologies (POET), with volume about twice typical levels and higher implied volatility, has pulled the stock onto traders’ radar ahead of the upcoming earnings report. See our latest analysis for POET Technologies. Beyond the options spike, POET Technologies’ share price has moved to $8.09, with a 30 day share price return of 36.20% and a 1 year total shareholder return of 60.83%, suggesting momentum has been building over both shorter and longer...

Travelers Companies (TRV) has been drawing fresh attention after recent share price swings, with the stock up about 0.6% over the past day but down 6.1% over the past month. See our latest analysis for Travelers Companies. The recent pullback, including a 6.1% 1 month share price return decline, comes against a stronger backdrop, with a 1 year total shareholder return of 15.5% and 5 year total shareholder return of 107.9%. This suggests that longer term momentum has been resilient even as...

Progyny recently told investors at the J.P. Morgan Healthcare Conference in San Francisco that it expects its fourth quarter and full-year 2025 results to come in slightly above the financial guidance it issued in November, helped by stronger-than-anticipated member engagement late in the year. This guidance update suggests that Progyny’s underlying benefits platform usage remained resilient despite leadership changes, underscoring how member engagement can directly influence its financial...

GSI Technology has announced a government-funded proof-of-concept with Israel’s G2 Tech and two agencies, including the U.S. Department of War, to integrate its Gemini-II compute-in-memory APU into Sentinel, an autonomous perimeter security system coordinating drones and cameras for real-time monitoring and response. Around US$1,000,000 in expected funding to optimize and integrate Gemini-II into a mission-critical defense application underscores the technology’s relevance for on-device AI...

In early 2026, Counterpart Health, a subsidiary of Clover Health Investments, reported 2025 results showing wider clinician adoption of its AI-powered physician enablement platform, stronger quality metrics including the top HEDIS score nationwide for a PPO Medicare Advantage plan, and reductions in hospitalizations and readmissions for chronic diseases. The rollout of integrated ambient scribing, natural language chat, and enterprise-level tools suggests Clover’s AI platform is moving...

On 12 January 2026, Zscaler, Inc. appointed Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering to architect security for autonomous AI agents and further expand its Zero Trust Exchange platform. This hire highlights Zscaler’s push deeper into the AI security stack, aiming to address emerging risks at the platform architecture level rather than through isolated point tools. We’ll now examine how Kocherlakota’s focus on agentic AI security could influence...

AOP Health US has expanded U.S. distribution of Rapiblyk (landiolol) through several wholesalers, including McKesson (MCK). This expansion gives hospitals wider access to this FDA approved critical care cardiac therapy. See our latest analysis for McKesson. For McKesson, participation in the expanded Rapiblyk distribution sits against a backdrop of firm share price momentum, with the stock at $834.16 and a 90 day share price return of 7.57%. Over longer horizons, total shareholder returns of...

What Recent Returns Say About Encompass Health (EHC) Encompass Health (EHC) has drawn attention after a period of mixed share performance, with a 1 day slip, a roughly 6% decline over the past week and a steeper drop over the past 3 months. At the same time, the stock shows a 1 year total return of about 8% and a 3 year total return of around 67%, while the 5 year total return is near 54%, giving investors a broad set of reference points. See our latest analysis for Encompass Health. Recent...

If you are wondering whether Grab Holdings is offering fair value at its recent price of US$4.63, you are not alone. This article is built to help you frame that question clearly. The share price has seen a 8.9% decline over the last week and a 7.8% decline over the past month, although it is up 3.8% over 1 year and 24.8% over 3 years, while still sitting 68.9% below its 5 year level. These moves come as investors continue to weigh the prospects of Grab's core ride hailing, deliveries, and...

Savara (SVRA) is back in focus after the company disclosed an exclusive US distribution deal with PANTHERx Rare Pharmacy for MOLBREEVI, tied to a recent FDA Biologics License Application and Priority Review request. See our latest analysis for Savara. The exclusive MOLBREEVI agreement comes after a strong period for Savara, with a 90 day share price return of 67.6% and a 1 year total shareholder return of 94.17%. However, the 30 day share price return of 9.23% suggests some cooling in the...